PF-03654746
PF-03654746 is a drug candidate from Pfizer that blocks histamine H3 receptors in the brain. By blocking these receptors, it can influence the release of histamine and other brain chemicals, which may affect attention, wakefulness, and movement. The compound has been studied in clinical trials for conditions like ADHD and Tourette syndrome, and researchers are also exploring potential allergy-related uses. It is not yet approved for medical use and is still in development.
This page was last edited on 2 February 2026, at 07:12 (CET).